Factors Associated With PASI90 Maintenance Without Flare-Up and Predictors of Biologics Discontinuation in Psoriasis: Two-Center Retrospective Cohort Study in Korea. [PDF]
Choi MS +5 more
europepmc +1 more source
Secukinumab for lamellar ichthyosis in an adolescent: a case report. [PDF]
Li L, Wei F.
europepmc +1 more source
Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study. [PDF]
Ibba L +29 more
europepmc +1 more source
Cutaneous Crohn's disease unmasked during interleukin 17 inhibition for hidradenitis suppurativa: A 2-patient case series. [PDF]
Zegeye Y +6 more
europepmc +1 more source
Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry. [PDF]
Wen J +5 more
europepmc +1 more source
Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison. [PDF]
Mease PJ +8 more
europepmc +1 more source
Trajectory-based profiling of 52-week secukinumab response reveals baseline clinical and transcriptomic differences in plaque psoriasis. [PDF]
Wang X +5 more
europepmc +1 more source
Modalities of Combined Medical and Surgical Treatment in Hidradenitis Suppurativa: A Systematic Review of Efficacy and Safety. [PDF]
Mateu-Arrom L +2 more
europepmc +1 more source
Clinical efficacy analysis of secukinumab combined with calcipotriol cream in the treatment of moderate to severe psoriasis in elderly patients. [PDF]
Lin L +10 more
europepmc +1 more source

